ARTICLE | Company News
Avanir acquires MIF technology
August 9, 2001 7:00 AM UTC
AVN acquired macrophage migration inhibitory factor (MIF) technology from Ciblex (San Diego, Calif.). The acquisition gives AVN worldwide rights to Ciblex's MIF technology for inflammatory and autoimm...